Delaware Commission Moves Foward with Medication Rule Updates: THA Racing.Com 3/9/17

By: Tom LaMarra The Delaware Thoroughbred Racing Commission has published several rule modifications, including those related to out-of-competition testing and the Multiple Medication Violation Penalty System, and is poised to adopt them in April following a mandatory 30-day public comment period. The DTRC took the action during its March 8 meeting. The next meeting is

New York Tweaks, Re-Proposes Anti-Stacking Rules for NSAIDS: TDN 2/27/17

By: T.D. Thornton By unanimous voice vote, the New York State Gaming Commission (NYSGC) tweaked and re-proposed a rule Feb. 27 regarding the use of multiple non-steroidal anti-inflammatory drugs (NSAIDs) before horse races in order to eliminate the practice known as “stacking” of those medications while still allowing a second NSAID to be used if

Kentucky Rescinds Dextrophan Positives: Blood-Horse 2/21/17

By: Frank Angst Citing new research that suggests the metabolite of Dextromethorphan, Dextrorphan, can stay in a horse's system at a wider variance of time than previously realized, the Kentucky Horse Racing Commission earlier this year dropped sanctions in three cases where the metabolite was discovered. KHRC equine medical director Mary Scollay offered a presentation

ARCI Names Members of New Model Rule Compliance Panel: THA Racing.Com 2/1/17

By: Tom LaMarra Three former racing regulators have been chosen to sit on a panel that will certify jurisdictional compliance with integrity standards each year—the components of the National Uniform Medication Program will be the focal point for 2017. The Association of Racing Commissioners International Feb. 1 named Steve Barham, Bennett Liebman and Allan Monat

With Eye Toward Uniformity, Kentucky Reviews Drug Rules: Blood-Horse 2/1/17

By: Frank Angst After an in-depth review of its racing medication rules relative to the Association of Racing Commissioners International’s recommendations, a Kentucky council is recommending penalty classification changes for a pair of medications. The Kentucky Equine Drug Research Council recommended Feb. 1 that the expectorant ambroxol (Ambril) be moved to a more severe penalty

WV Makes Serious Push to Facilitate Quicker Model Rule Adoption: THA Racing.Com 1/24/17

By: Tom LaMarra The West Virginia Racing Commission has agreed to ask state government officials to help facilitate quicker adoption of two important model rules approved by the Association of Racing Commissioners International in December. The WVRC at its Jan. 24 meeting also announced plans to expand its out-of-competition testing program this year beyond the

NYSGC Proposes Overhaul of Drug, Veterinary Rules: TDN 1/23/17

By: T.D. Thornton Five proposed new rules dealing with Thoroughbred medication, prohibited substances, minimum drug penalties, out-of-competition testing, and airway bleeding in racehorses were advanced to a 45-day public-comment period by the New York State Gaming Commission (NYSGC) at the board’s monthly meeting Jan. 23. Board members only briefly discussed specifics of the broad set

MD. Racing Commission Adopts ARCI Penalty Guides: The Racing Biz 10/18/16

By: Frank Vespe In a moment of what Yogi Berra might have called “deja vu all over again,” the Maryland Racing Commission on Tuesday adopted the Association of Racing Commissioners International model rules on medication penalties — rules that most observers thought the Commission had adopted back in 2014. By unanimous vote, the Commission directed

ARCI Updates Model Rules Of Racing: Paulick Report 9/18/16

By: Press Release An updated version (6.3) of the Association of Racing Commissioners International's Model Rules of Racing is now available on the association's website on the Model Rules and Standards page.  (www.arci.com). The ARCI Model Rules represent the racing industry's best practice regulatory standards, developed in consultation with industry constituencies and adopted by the